Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
FCF to Net Income | 120.9% | 156.2% | 80.4% | 140.9% | 204.1% | 178.0% | 119.9% | 184.9% | 107.7% | 73.8% | 166.9% | 186.3% | 191.9% | 66.7% | 121.8% | 61.3% | 165.4% | 133.0% | 82.9% | 220.7% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month FCF to Net Income is 192.5%, based on the financial report for Sep 29, 2024 (Q3 2024). The average annual FCF to Net Income for Pfizer Inc. have been (20.0%) over the past three years, and 13.7% over the past five years.
As of today, Pfizer Inc.'s FCF to Net Income is 192.5%, which is higher than industry median of 109.5%. It indicates that Pfizer Inc.'s FCF to Net Income is Good.